Novo Nordisk rebrands to 'Novo,' unveils corporate changes as it fights for obesity market share
Headline as filed by CNBC Top News.
Compare coverage — 1 report
| Publisher | Headline | Summary | Published | Detected | Delay | Source | Status |
|---|---|---|---|---|---|---|---|
| CNBC Top News | Novo Nordisk rebrands to 'Novo,' unveils corporate changes as it fights for obesity market share |
The Danish drugmaker called the changes the beginning of a new chapter for the company, which faces stiff competition from Eli Lilly. |
0m | cnbc.com | First |
Headlines and summaries belong to the publisher named beside them. “Published” is what their feed stated; “detected” is when PageNews first held the report. Delay is measured from the earliest report on this event and describes timing only.
Reader comments
Comments are written by readers. PageNews does not check them and does not stand behind them, and a name here is a name someone typed, not a person we have identified.
Nobody has commented on this story yet.